Search - tctmd.com

Displaying 281 - 300 of 568

Sort: Relevancy | Date

Presentation TCT 2019

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

Presenter: Clifford Kavinsky

September 27, 2019

Presentation TCT 2019

PFO in 2019, A Neurologist’s Perspective

Presenter: David Thaler

September 27, 2019

Presentation TCT 2019

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

Presenter: Andrew Goldsweig, MD

September 27, 2019

Presentation TCT 2019

PFO Closure for Primary Prevention: The Debate Has Started — A Case Example and a Clinical Trial Proposal

Presenter: Fabian Nietlispach

September 27, 2019

Presentation TCT 2019

PFO Closure for Stroke: The Debate Is Over

Presenter: Stephen Brecker

September 27, 2019

Presentation TCT 2019

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Tackling Inflammation: Novel Targets

Presenter: Wolfgang Koenig

September 26, 2019

Presentation TCT 2019

LP(a): Not So Little Anymore

Presenter: Roberta Rossini

September 26, 2019

Presentation TCT 2019

Don’t Forget About Your HDL: The AEGIS Program

Presenter: C. Michael Gibson

September 26, 2019

Presentation TCT 2019

Role of PCSK9 Inhibitors Post-PCI and ACS

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Loading Dose Statin Prior PCI: Is There a Role For It?

Presenter: Renato Lopes

September 26, 2019

Presentation TVT 2019

Prevention of Cardiac Maternal Mortality in the Developing World: Screening Pregnant Women in Hyderabad, India for Structural Heart Disease

Presenter: Amisha Patel

June 14, 2019

Presentation TVT 2019

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

Presenter: Megan Coylewright

June 14, 2019

Presentation TVT 2019

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

Presenter: Zahid Amin

June 14, 2019

Presentation TVT 2019

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Presenter: Fabian Nietlispach

June 14, 2019

Presentation TVT 2019

Prevention and Management of Bioprosthetic Valve Thrombosis

Presenter: Raj Makkar

June 13, 2019

Presentation ARCH 2019

Evaluation of Hypotension in or after the Cath Lab

Presenter: Adrian Messerli

April 11, 2019

Presentation CIT 2019

Prevention and Management of Cardiovascular Collapse in CHIP PCI

Presenter: Jun Jiang

March 28, 2019

Presentation CIT 2019

No-Reflow in CHIP: Risk evaluation, Prevention, and Treatment

Presenter: Li Yue

March 28, 2019

Presentation JIM 2019

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Presenter: Maurice Buchbinder

February 14, 2019

Advertisement

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

PFO in 2019, A Neurologist’s Perspective

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

PFO Closure for Primary Prevention: The Debate Has Started — A Case Example and a Clinical Trial Proposal

PFO Closure for Stroke: The Debate Is Over

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Tackling Inflammation: Novel Targets

LP(a): Not So Little Anymore

Don’t Forget About Your HDL: The AEGIS Program

Role of PCSK9 Inhibitors Post-PCI and ACS

Loading Dose Statin Prior PCI: Is There a Role For It?

Prevention of Cardiac Maternal Mortality in the Developing World: Screening Pregnant Women in Hyderabad, India for Structural Heart Disease

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Prevention and Management of Bioprosthetic Valve Thrombosis

Evaluation of Hypotension in or after the Cath Lab

Prevention and Management of Cardiovascular Collapse in CHIP PCI

No-Reflow in CHIP: Risk evaluation, Prevention, and Treatment

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content